This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Jennifer Martin
Senior Advisor, ADME at Eli Lilly and Company
Speaker

Profile

Jennifer A Martin, MS is a Senior Advisor in Drug Disposition at Eli Lilly and Company in Indianapolis, Indiana. Jennifer designs, analyzes, and interprets studies for the absorption/distribution/metabolism/excretion (ADME) of large molecules with a primary focus on peptides and fusion proteins in support of ADME, pharmacology, and toxicology studies. She provides scientific consultation and expertise on cross-functional program teams to recommend selection of drug candidates for development, design development plans, and prepare for worldwide regulatory submissions.

Agenda Sessions

  • ADME and PK Considerations (Invited)

    9:45am